LONDON — The rapid rise of GLP-1 weight-loss medications is creating an unexpected challenge for the nutrition industry: a growing shortage of whey protein is driving prices to record levels and forcing manufacturers to compete for limited supplies.
Industry analysts say soaring consumer demand for medications such as Mounjaro is reshaping the global protein market. Healthcare providers often recommend that patients taking GLP-1 drugs increase their protein intake to help preserve muscle mass while losing weight, adding a new source of demand to an already expanding market for protein-rich foods and supplements.
Whey protein, derived from milk during the cheese-making process, has long been a staple in sports nutrition products because it contains all nine essential amino acids and is easily absorbed by the body. More recently, it has become a key ingredient in a growing number of mainstream products as consumers increasingly prioritize protein in their diets.
The result has been a sharp increase in prices.
Food-grade whey powder prices in northwestern Europe have climbed to about €1,700 ($1,940) per metric ton, the highest level on record and more than 50% above the start of the year, according to DCA Market Intelligence. Data from the dairy commodity intelligence platform Vesper shows that the price of whey protein concentrate with 80% protein has risen from about £4,300 ($5,820) per ton in June 2023 to nearly £23,800 ($32,220) per ton this year.
“If you look at overall supply and demand, the market is still finding a home for the product, but there’s clearly a shortage in the sense that people want more than there physically is available,” Vesper analyst Jasper Endlich told The Guardian. “Manufacturers would like to produce more and build safety stocks, but they haven’t been able to do that.”
The protein boom extends well beyond traditional nutritional supplements. Manufacturers are increasingly adding protein to a wide range of products, including snack foods, baked goods, and convenience items, as consumers seek foods that support weight management and overall wellness.
The trend has accelerated alongside the growing popularity of GLP-1 therapies. Medications that reduce appetite often lead consumers to eat less overall, increasing the importance of nutrient-dense foods and adequate protein intake.
Market participants say supply constraints are becoming increasingly visible. A recent report from the U.S. Department of Agriculture’s Dairy Market News highlighted tightening supplies of whey protein concentrate, particularly WPC 34%, a widely used commercial dairy ingredient. The report noted rising prices across the market and indicated that some suppliers have already sold out for the remainder of 2026.
Industry sources also expect further pressure on supplies after one manufacturer reportedly plans to stop producing WPC 34% later this year.
Despite the challenges, analysts say the industry is adapting. New production facilities are coming online, and some manufacturers are reformulating products to use blends of whey and milk proteins that deliver comparable nutritional benefits at lower cost.
“We’re seeing new production plants open,” Endlich said. “Where products may once have contained only whey protein, some are now using blends with a small amount of milk protein mixed in. The overall protein content remains broadly similar, but the ingredient cost can be half or even a third of the price.”
For smaller companies, however, the current environment presents significant challenges.
Erika Tamayo, founder of the protein brand Hermosa, said her company has seen repeated increases in ingredient costs over the past two years and is now paying roughly double what it paid for protein supplies in the previous quarter.
“We are now all fighting for stock allocation,” Tamayo told The Guardian. “Some of the bigger companies have absorbed all the price increases as they’re all trying to get market share and grow their businesses. Bigger players have more possibilities, so they don’t have to compromise.”
She added that the broader focus on protein has transformed the marketplace, with products ranging from popcorn and chips to doughnuts now being marketed as protein-enhanced.
“The challenge is managing lead times and availability,” Tamayo said. “Every quarter we have to wait and see how much supply is available, while also buying months in advance to make sure we don’t run out of stock.”
For retailers, pharmacies, and nutrition brands, the whey protein shortage underscores the far-reaching impact of the GLP-1 revolution. As more consumers adopt weight-loss medications and pursue higher-protein diets, demand for key nutritional ingredients is expected to remain elevated, keeping pressure on supply chains and prices until additional production capacity comes online.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
